Benfotiamine And Diabetic Retinopathy


Damage from diabetes can occur in different areas of the eye. It can occur to the cornea, nerves controlling the muscles of the eye, the lens, optic nerve and retina. The retina is the complication that most people and medical professionals think of first in terms of diabetic complications.

Diabetic retinopathy is simply damage to the light sensitive retina. This damage is brought about by hyperglycemia, the medical term for high blood sugar. Retinopathy is directly responsible for approximately 12,000 to 24,000 cases of legal blindness every year in the USA alone. It is reported that there are over 200,000 cases each year globally.

Diabetic complications are even more insidious than these numbers because there are several other types of diabetic eye disease created wholly or in part by high blood sugar in diabetics.

What Can Be Done To Prevent Eye Disease?

It stands to reason that the more informed a person is about a particular situation the better equipped they will be to handle it. Diabetic eye disease is just such a case in point. We need to think of the whole person and not just the eyes when discussing diabetic education because diabetic complications run from eye disease, heart disease, nerve damage, kidney damage, etc. Although benfotiamine has been found useful for all of the above, for the sake of this article in terms of prevention, we will discuss diabetic eye disease in terms of diabetic retinopathy.

Diabetic retinopathy is a disease that every diabetic faces the possibility of suffering from somewhere in the course of their disease. The better patients of diabetes are equipped to handle their disease, the lower their risk that they will develop retinopathy. If retinopathy does develop in a patient who is doing all he/she can do to lessen the impact of blood sugar on their bodies, the better chance that they can live productive lives despite the complications and the slower such complications will progress.

What Works Best?

Unfortunately, there are very few options that are showing much promise for the diabetic in terms of diabetic complications. Benfotiamine has been suggested recently to be a strong deterrent against the development of diabetic retinopathy and also shown to slow its progression significantly if it develops. It is showing great promise in the arena of retinopathy, neuropathy and heart/circulatory conditions brought about by excess sugar in the cells.

Benfotiamine, a lipid soluble derivative of water soluble vitamin B1 (thiamine), has been used for the past 12 years in Europe for the treatment of neuropathy, retinopathy as well as heart and circulatory conditions and has shown no adverse effects.

Much of the current research on benfotiamine can be discovered by typing the term benfotiamine into a search engine such as google, AOL, yahoo, etc.

Conclusion

Diabetic complications are a reality that must be an accepted possibility for every diabetic. Diabetic education is highly necessary so that the diabetic community is able to make informed decisions as to their treatment and prevention methodologies. There are few things that show great promise in preventing and/or helping neuropathy, retinopathy, heart and circulatory problems brought about by diabetes. Keeping blood sugar levels close to normal along with adequate exercise in line with the abilities of each individual has shown to help slow the onset of diabetic complications.

Benfotiamine is a nutritional supplement that has shown to be helpful in Europe over the past 12 years in terms of diabetic complications and is now available in the United States, and might be worth the time to investigate further. How about for the diabetic who faces the insidious nature of diabetic complications?

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy. He can be reached at:

Phone: 505.354.0526

web site: http://www.emuhealthproducts.com/benfotiamine.html







Related News




Risk Factors Identified for Recurrent Cardiac Events in Type 2 ... - Medscape

Risk Factors Identified for Recurrent Cardiac Events in Type 2 ...
Medscape -6 hours ago
Report the incidence of recurrent major cardiovascular disease in adults with type 2 diabetes mellitus. Describe the risk factors for recurrent ...

DexCom(TM) Receives CE Mark Approval for the SEVEN(R) Continuous ... - MarketWatch

DexCom(TM) Receives CE Mark Approval for the SEVEN(R) Continuous ...
MarketWatch -18 hours ago
The SEVEN is DexCom's second generation device designed to help people with diabetes better manage their diabetes and control their glucose levels. ...

USF steps up diabetes initiative, Krischer to fill endowed chair - Bizjournals.com

USF steps up diabetes initiative, Krischer to fill endowed chair
Bizjournals.com, NC -12 hours ago
The university-bestowed endowment will build upon the success of the Diabetes and Pediatrics Epidemiology Centers directed by Krischer, ...

USF Fills New Endowed Chair In Diabetes Research - Tampa Tribune

USF Fills New Endowed Chair In Diabetes Research
Tampa Tribune, FL -10 hours ago
By ADAM EMERSON | The Tampa Tribune Aiming to capitalize on its success in its fight against diabetes, the University of South Florida named one of its ...
Accounting wins kudo at USFTampabay.com
Offense Faces Difficult TaskTampa Tribune
all 3 news articles

Diabetes expert to speak at presidential lecture series - Bizjournals.com

Diabetes expert to speak at presidential lecture series
Bizjournals.com, NC -12 hours ago
Dr. Kahn is with the Joslin Diabetes Center in Boston, where he has helped define the molecular mechanisms of insulin interactions at the cellular level. ...

Diabetes, obesity metabolic link studied - United Press International

Diabetes, obesity metabolic link studied
United Press International -10 hours ago
"In the fight against the obesity and diabetes epidemics, disruption of NCoR and its enzyme partner might be a valuable new weapon," said Lazar. ...

Are You an Athlete with Diabetes? Then You Need This Book! (Part 2) - Diabetes Health (press release)

Diabetes Health (press release)

Are You an Athlete with Diabetes? Then You Need This Book! (Part 2)
Diabetes Health (press release), CA -7 hours ago
Dr. Colberg has a PhD in exercise physiology, is a Diabetes Health board member, and is herself an athlete with diabetes. ...
Living with Diabetes: A Father of A Child with Type 1 Child Warns ...Diabetes Health (press release)
all 2 news articles

Lexicon files application for diabetes drug - CNNMoney.com

Woodlands Online, LLC

Lexicon files application for diabetes drug
CNNMoney.com -8 hours ago
Type 2 diabetes is characterized by moderately diminished production of insulin, a hormone that regulates blood glucose levels. Type 1 diabetes is generally ...
Lexicon Files Investigational New Drug Application for LX4211 as a ...MarketWatch
all 13 news articles

Eye on Health - Diabetes Family | KXNet.com North Dakota News - Reiten Television KXMB Bismarck

Eye on Health - Diabetes Family | KXNet.com North Dakota News
Reiten Television KXMB Bismarck, ND -Nov 30, 2008
For the past few weeks we have examined National Diabetes month in our Eye on Health Segments. Tonight, we learn about Type One Diabetes. ...

Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and ... - MarketWatch

Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and ...
MarketWatch -14 hours ago
"There is no question that better management of diabetes results in better outcomes for the patient," Aspy said. "By offering a lancing device that results ...